Optimal beam arrangement for stereotactic body radiation therapy delivery in lung tumors

Acta Oncologica

Volumn 49, Issue 2, 2010, Pages 219-224

  Lim, Do Hoon ^a,b   Yi, Byong Yong ^a   Mirmiran, Ali ^a   Dhople, Anil ^a   Suntharalingam, Mohan ^a   D'Souza, Warren D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Sungkyunkwan University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; DOSIMETRY; FEMALE; HUMAN; INOPERABLE CANCER; LUNG TUMOR; MALE; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE; STEREOTACTIC BODY RADIATION THERAPY;

AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PRACTICE GUIDELINES AS TOPIC; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 76649098539     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841860903302897     Document Type: Article

References (21)

1. Graham PH, Gebski VJ, Langlands AO. Radical radiotherapy for early nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1995;31:261-6.
2. Qiao X, Tullgren O, Lax I, Sirzen F, Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 2003;41:1-11.
3. Krol A D, Aussems P, Noordijk EM, Hermans J, Leer JW. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys 1996;34:297-302.
4. Haffty BG, Goldberg NB, Gerstley J, Fischer DB, Peschel RT. Results of radical radiation therapy in clinical stage I technically operable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1988;15:69-73.
5. Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Salenius S, Rashid M, et al. Radiation therapy in the management of medically inoperable carcinoma of the lung:Results and implications for future treatment strategies. Int J Radiat Oncol Biol Phys 1992;24:3-9.
6. Nagata Y, Takayama K, Matsuo Y, Norihisa Y, Mizowaki T, Sakamoto T, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005;63:1427-31.
7. McGarry RC, Papiez L, Williams M, Whitford T, Timmerman RD. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma:Phase I study. Int J Radiat Oncol Biol Phys 2005;63:1010-5.
8. Timmerman R, Papiez L, MaGarry R, Likes L, DesRosiers C, Frost S, et al. Extracranial stereotactic radioablation:Results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 2003;124:1946-55.
9. Hoyer M, Roed H, Hansen AT, Ohlhuis L, Petersen J, Nellemann H, et al. Prospective study on stereotactic radiotherapy of limited-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2006;66:s128-35.
10. Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma:Clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 2004;101:1623-31.
11. Uematsu M, Shioda A, Suda A, Fukui T, Ozeki Y, Hama Y, et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell cancer:A 5-year experience. Int J Radiat Oncol Biol Phys 2001;51:666-70.
12. Fukumoto S, Shirato H, Shimizu S, Ogura S, Onimaru R, Kitamura K, et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fi elds for patients with inoperable stage I nonsmall cell lung carcinomas. Cancer 2002;95:1546-53.
13. Onimaru R, Shirato H, Shimizu S, Kitamura K, Xu B, Fukumoto S, et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 2003;56:126-35.
14. Bral S, Van Parijs H, Soete G, Linthout N, Van Moorter L, Verellen D, et al. A feasibility study of image-guided hypofractionated conformal arc therapy for inoperable patients with localized non-small cell lung cancer. Radiother Oncol 2007;84:252-6.
15. Wulf J, Baier K, Mueller G, Flentje MP. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005;77:83-7.
16. Timmerman R, Galvin J, Michalski J, Straube W, Ibbott G, Martin E, et al. Accreditation and quality assurance for Radiation Therapy Oncology Group:Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer. Acta Oncol 2006;45:779-86.
17. Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer 2006;51:97-103.
18. Uematsu M, Shioda A, Tahara K, Fukui T, Yamamoto F, Tsumatori G, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients:A preliminary experience. Cancer 1998;82:1062-70.
19. Bo X, Shirato H, Shimizu S, Arimoto T, Kagei K, Kitahara T, et al. Dose-volume analysis of stereotactic irradiation for lung tumors. J Radiosurg 1999;2:239-45.
20. Takayama K, Nagata Y, Negoro Y, Mizowaki T, Sakamoto T, Sakamoto M, et al. Treatment planning of stereotactic radiotherapy for solitary lung tumor. Int J Radiat Oncol Biol Phys 2005;61:1565-71.
21. Liu R, Buatti JM, Howes TL, Dill J, Modrick JM, Meeks SL. Optimal number of beams for stereotactic body radiotherapy of lung and liver lesions. Int J Radiat Oncol Biol Phys 2006;66:906-12.